MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma

International Journal of Oncology

Volumn 48, Issue 3, 2016, Pages 965-974

  Tu, Kangsheng ^a   Liu, Zhikui ^a   Yao, Bowen ^a   Han, Shaoshan ^a   Yang, Wei ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; MicroRNA 519a; Phosphatase and tensin homolog; PI3K AKT signaling; Tumor growth

Indexed keywords

8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; CYCLIN D1; DNA; MESSENGER RNA; MICRORNA; MICRORNA 519A; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN P27; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MIRN519 MICRORNA, HUMAN; PTEN PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INFILTRATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA SYNTHESIS; ECTOPIC EXPRESSION; FEMALE; FLOW CYTOMETRY; GAIN OF FUNCTION MUTATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MTT ASSAY; OVERALL SURVIVAL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; CELL CYCLE; GENE EXPRESSION REGULATION; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PROGNOSIS; TUMOR CELL LINE;

AGED; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 84959018584     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.3309     Document Type: Article

References (32)

1. Bosch FX, Ribes J, Díaz M and Cléries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 127 (Suppl 1): S5-S16, 2004
2. El-Serag HB and Rudolph KL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007
3. Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, et al; Panel of Experts in HCC-Design Clinical Trials: Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100: 698-711, 2008
4. Talwalkar JA and Gores GJ. Diagnosis and staging of hepatocellular carcinoma. Gastroenterology 127 (Suppl 1): S126-S132, 2004
5. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism and function. Cell 116: 281-297, 2004
6. Rosa A and Brivanlou AH. MicroRNAs in early vertebrate development. Cell Cycle 8: 3513-3520, 2009
7. Vasudevan S, Tong Y and Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 318: 1931-1934, 2007
8. Tu K, Zheng X, Dou C, Li C, Yang W, Yao Y and Liu Q. MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-Activated receptor gamma in human hepatocellular carcinoma. Int J Mol Sci 15: 20486-20499, 2014
9. Dou C, Wang Y, Li C, Liu Z, Jia Y, Li Q, Yang W, Yao Y, Liu Q and Tu K. MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1. Oncotarget 6: 13216-13228, 2015
10. Chang RM, Yang H, Fang F, Xu JF and Yang LY. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase. Hepatology 60: 1251-1263, 2014
11. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y and Zhuang SM. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 69: 1135-1142, 2009
12. Yang X, Zhang XF, Lu X, Jia HL, Liang L, Dong QZ, Ye QH and Qin LX. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factorcMet pathway. Hepatology 59: 1874-1885, 2014
13. Santhekadur PK, Das SK, Gredler R, Chen D, Srivastava J, Robertson C, Baldwin AS Jr, Fisher PB and Sarkar D. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor ?B and miR-221. JBiol Chem 287: 13952-13958, 2012
14. Kim TH, Kim YK, Kwon Y, Heo JH, Kang H, Kim G and An HJ. Deregulation of miR-519a, 153 and 485-5p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology 57: 734-743, 2010
15. Ward A, Shukla K, Balwierz A, Soons Z, König R, Sahin O and Wiemann S. MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer. J Pathol 233: 368-379, 2014
16. Abdelmohsen K, Srikantan S, Tominaga K, Kang MJ, Yaniv Y, Martindale JL, Yang X, Park SS, Becker KG, Subramanian M, et al. Growth inhibition by miR-519 via multiple p21-inducing pathways. Mol Cell Biol 32: 2530-2548, 2012
17. Abdelmohsen K, Srikantan S, Kuwano Y and Gorospe M. miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc Natl Acad Sci USA 105: 20297-20302, 2008
18. Yang W, Dou C, Wang Y, Jia Y, Li C, Zheng X and Tu K. MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7. Oncol Rep 34: 2576-2584, 2015
19. Jiang L, Wang C, Lei F, Zhang L, Zhang X, Liu A, Wu G, Zhu J and Song L. miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway. Oncotarget 6: 8286-8299, 2015
20. Garzon R, Calin GA and Croce CM. MicroRNAs in Cancer. Annu Rev Med 60: 167-179, 2009
21. Croce CM and Calin GA. miRNAs, cancer and stem cell division. Cell 122: 6-7, 2005
22. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al. MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005
23. Marasa BS, Srikantan S, Martindale JL, Kim MM, Lee EK, Gorospe M and Abdelmohsen K. MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence. Aging (Albany NY) 2: 333-343, 2010
24. Abdelmohsen K, Kim MM, Srikantan S, Mercken EM, Brennan SE, Wilson GM, Cabo R and Gorospe M. miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle 9: 1354-1359, 2010
25. Courtney KD, Corcoran RB and Engelman JA. The PI3K pathway as drug target in human cancer. J Clin Oncol 28: 1075-1083, 2010
26. Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C and González-Barón M. PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30: 193-204, 2004
27. Cheng GZ, Park S, Shu S, He L, Kong W, Zhang W, Yuan Z, Wang LH and Cheng JQ. Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr Cancer Drug Targets 8: 2-6, 2008
28. Cappellini A, Tabellini G, Zweyer M, Bortul R, Tazzari PL, Billi AM, Falà F, Cocco L and Martelli AM. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. Leukemia 17: 2157-2167, 2003
29. Song MS, Salmena L and Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13: 283-296, 2012
30. Cantley LC and Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96: 4240-4245, 1999
31. Rahman MA, Kyriazanos ID, Ono T, Yamanoi A, Kohno H, Tsuchiya M and Nagasue N. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: Possible relationship with COX II and inducible nitric oxide synthase. Int J Cancer 100: 152-157, 2002
32. Tamura M, Gu J, Tran H and Yamada KM. PTEN gene and integrin signaling in cancer. J Natl Cancer Inst 91: 1820-1828, 1999